NON-METASTATIC UNRESECTABLE INTRA-HEPATIC CHOLANGIOCARCINOMA research hub

GEMOXIA02: HEPATIC ARTERIAL INFUSION OF GEMCITABINE-OXALIPLATIN FOR SECOND-LINE THERAPY IN NON-METASTATIC UNRESECTABLE INTRA-HEPATIC CHOLANGIOCARCINOMA: A MULTICENTRIC SINGLE-ARM PHASE II STUDY

This clinical trial is testing a targeted way to deliver chemotherapy directly into the liver for people with bile duct cancer. Doctors are studying whether giving two medicines straight into the liver's blood supply can shrink tumours that cannot be removed by surgery and have stopped responding to standard treatments.